Genmab | GEN - Sales Revenues


Genmab reported DKK1.16B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Agios Pharmaceuticals USD 55.38M 10.64M Sep/2026
Almirall EUR 602.71M 55.09M Jun/2026
Amarin USD 49.22M 451K Dec/2025
Amgen USD 10.4B 300M Sep/2026
argenx SE USD 1.72B 361M Sep/2026
AstraZeneca USD 16.21B 830M Sep/2026
Bayer EUR 10.05B 820M Sep/2026
BioMarin Pharmaceutical USD 1.03B 40M Sep/2026
Demant DKK 6.67B 420M Jun/2026
Exelixis USD 658.69M 30M Sep/2026
Fresenius Medical Care EUR 4.94B 80M Sep/2026
Genmab DKK 1.16B 259M Jun/2026
GlaxoSmithKline GBP 8.89B 480M Sep/2026
GN Store Nord DKK 2.27B 100M Sep/2026
GRIFOLS EUR 2.04B 170M Sep/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Insmed USD 524.42M 98.93M Sep/2026
Lakefront Biotherapeutics EUR 7.11M 5M Sep/2026
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.63B 200M Sep/2026
Novartis USD 14.52B 112M Sep/2026
Regeneron Pharmaceuticals USD 5.12B 830M Sep/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sanofi EUR 14.44B 2.49B Sep/2026
UCB EUR 4.25B 764M Dec/2025